We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
257 hedge funds and large institutions have $4.77B invested in Madrigal Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 87 increasing their positions, 83 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
26% more call options, than puts
Call options by funds: $208M | Put options by funds: $165M
5% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 83
2% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 43
0% more funds holding
Funds holding: 257 → 257 (0)
2.89% less ownership
Funds ownership: 107.33% → 104.43% (-2.9%)
25% less capital invested
Capital invested by funds: $6.41B → $4.77B (-$1.63B)
36% less funds holding in top 10
Funds holding in top 10: 14 → 9 (-5)
Holders
257
Holders Change
–
Holders Change %
0%
% of All Funds
3.69%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.13%
New
44
Increased
87
Reduced
83
Closed
43
Calls
$208M
Puts
$165M
Net Calls
+$43.4M
Net Calls Change
-$82.5M
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
+$49.1M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$47M |
| 3 |
State Street
Boston,
Massachusetts
|
+$36.6M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$20.1M |
| 5 |
RI
RTW Investments
New York
|
+$19.9M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$74.1M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$41.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32M |
| 4 |
AC
Armistice Capital
New York
|
-$25.6M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$17.8M |
